About

Seth Hetherington, M.D. is a clinical development consultant to biotech companies. Dr. Hetherington earned his B.S. at Yale University and his M.D. at the University of North Carolina, Chapel Hill. He completed his postgraduate training in pediatrics and pediatric infectious diseases at the University of North Carolina and the University of Minnesota, respectively. Dr. Hetherington has published extensively in medical and scientific literature. Following a career in academics, he joined GlaxoSmithKline in the anti-viral clinical development group, and worked on multiple projects of new chemical entities from Phase 1 through approval. Subsequently he joined a series of start-up biotech companies as Chief Medical Officer creating and overseeing clinical development programs for both small molecules and biologics across multiple therapeutic areas. He has served as the industry representative to the Vaccines and Related Blood Products Advisory Committee of the FDA, the National Vaccine Advisory Committee of the U.S. Department of Health and Human Services, and several ad hoc review committees of the National Institutes of Health. He is based in Chapel Hill, North Carolina and is an adjunct clinical faculty member of the Department of Pediatrics at the University of North Carolina School of Medicine.